2022 International Congress Archives - Page 75 of 153

Impact of istradefylline on the adjustment of levodopa dose escalation in Parkinson’s disease: Results of the ISTRA ADJUST PD randomized, controlled study

T. Hatano, O. Kano, R. Sengoku, N. Yanagisawa, H. Nagayama (Tokyo, Japan)
Impact of Nonmotor Symptoms on The Quality of Life of Parkinson’s Disease Patients

R. Nindela, O. Tambun, S. Marisdina, E. Bahar (Palembang, Indonesia)
Impact of rs6265 in the Host and Donor on Dopamine Neuron Graft Function.

C. Szarowicz, M. Caulfield, J. Stancati, M. Vanderwerp, C. Sortwell, J. Patterson, M. Benskey, T. Collier, K. Steece-Collier (Grand Rapids, USA)
Impact of SARS-CoV-2 vaccine in Parkinson’s disease

E. Reséndiz-Henríquez, E. Ichikawa-Escamilla, P. Bazán-Rodríguez, MA. Ruiz-Mafud, AJ. Hernández-Medrano, GI. Cerda-Hernández, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)
Impact of Th17 pathway-related immuno-inflammatory cytokines in the risk and severity of Parkinson’s Disease.

M. Debnath, M. Gothwal, N. Sreenivas, S. Dey, M. Thrinath, R. Yadav, PK. Pal, J. Saini (Bengaluru, India)
Impact of the delayed diagnosis in the prognosis of Parkinson’s disease.

E. Ichikawa-Escamilla, AJ. Hernández-Medrano, P. Bazán-Rodríguez, E. Reséndiz-Henríquez, GI. Cerda-Hernández, MA. Ruíz-Mafud, RA. Abundes-Corona, A. Cervantes-Arriaga, M. Rodríguez-Violante (Mexico City, Mexico)
Impact of the dopamine system on long-term, incident cognitive impairment in Parkinson disease

D. Weintraub, M. Picillo, H. Cho, C. Caspell-Garcia, C. Coffey, K. Marek, K. Poston, T. Simuni, J. Seibyl, A. Siderowf, A. Singleton, C. Tanner (Philadelphia, USA)
Impact of two different rechargeable pulse generators on parkinsonian patients with deep brain stimulation

C. Bogaert, C. Der Linden (Gent, Belgium)
Impact on non-motor symptoms, cognition, and QoL after 1-year of DBS for Parkinson’s Disease: An interim report from the ADROIT NAPA sub-study

M. Poetter-Nerger, S. Groppa, O. Adam, A. Schnitzler, M. Navas Garcia, B. Cheeran, L. Himes, M. Frassica, A. Gharabaghi (Hamburg, Germany)
Impaired behavioral proactive inhibitory control and flexibility in a mouse model of early Parkinson’s disease

J. Lhost, AM. Ouagazzal, M. Liberge, M. Amalric (Marseille, France)